2009
18.08.09
Looking to raise some cash? Against IP?
To the surprise of many, Morgan Stanley has just announced a new US$250 million intellectual property securitisation for Vertex Pharmaceuticals, a large US bio-tech company.

18.08.09
Looking to raise some cash? Against IP?
To the surprise of many, Morgan Stanley has just announced a new US$250 million intellectual property securitisation for Vertex Pharmaceuticals, a large US bio-tech company.
© 2001 - 2010 Wragge & Co LLP. Wragge & Co LLP is a Limited Liability Partnership, Registered No. OC304378.
Registered Office: 55 Colmore Row, Birmingham, B3 2AS; All rights reserved.